Recombinant canine herpesviruses
US5753235A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Feb 15, 1996 |
| Grant date | May 19, 1998 |
| Priority date | — |
| Expiry date | Feb 15, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16743
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes novel recombinant canine herpes virus (CHV) and novel recombinant CHV genomes, and particularly to those CHV and CHV genomes that contain heterologous nucleic acid molecules. The present invention also relates to the use of such genomes and viruses in a variety of applications, including as therapeutic compositions to protect animals from disease. The present invention also relates to novel isolated CHV nucleic acid molecules, to CHV proteins encoded by such nucleic acid molecules, and to antibodies raised against such CHV proteins as well as to the use of such CHV nucleic acid molecules, proteins and antibodies as therapeutic compositions to protect an animal from CHV. The present invention also includes constructs comprising CHV nucleic acid molecules that include heterologous nucleic acid molecules, to recombinant vectors including such constructs, and to the use of such constructs and vectors in the production of recombinant CHV and recombinant CHV genomes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.